Media Center
Press Releases

Press Releases

25 Mar 15
Antibiotics Pipeline Boasts 741 Products, but First-in-class Development Remains Low

While antibiotics boast a vast pipeline, with 741 products currently in development, the majority is dominated by generics, as weak financial incentives and high failure rates have discouraged innovation.

Read post
17 Mar 15
US Asthma Treatment Market Value to Hit $14 Billion by 2020, says GBI Research

The US treatment market for asthma will rise in value from $11.7 billion in 2013 to an estimated $14 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 2.6%.

Read post
10 Mar 15
Big Pharma Drives Innovation in Pain Therapy Development, Despite Declining Patent Applications

Patent applications for novel pain therapeutics declined steadily in number from 4,970 in 2008 to 3,492 in 2012, an average annual decrease of 8%, as limited understanding of pain pathophysiology continues to hinder drug development in this arena.

Read post
03 Mar 15
Pharmaceutical Industry Explores Innovative Ways to Treat Obesity in Women, says GBI Research

With obesity forecast to affect 50% of adult women by 2050, pharmaceutical companies are currently exploring a number of different approaches to treating the condition, which is known to increase the risk of many serious diseases.

Read post
24 Feb 15
Alzheimer’s Disease Treatment Pipeline Remains Large Despite 95% Attrition Rate, says GBI Research

While drug candidates for Alzheimer’s Disease (AD) fail at a much higher rate than the pharmaceutical industry average, the total number of active drugs in the AD treatment pipeline is relatively large at 583, implying a high level of commercial interest.

Read post